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Abstract
Age-related macular degeneration (AMD) is the most common cause of central
vision loss in developed world. Two genes on chromosome 10q26, maculopathy
susceptibility 2 (ARMS2) and HtrA serine peptidase 1 (HTRA1) were identified as
candidate genetic factors of AMD. However, due to the high linkage disequilibrium
across the locus as well as the inconsistent functional findings regarding the two genes,
it is difficult to distinguish the causative gene that confer the risk of AMD. To provide
insight of the functional roles of ARMS2 and HTRA1 in the pathogenesis of AMD, we
investigated the regulation relationship between the two genes in vivo. To overcome the
difficulty that ARMS2 gene only exists in higher primates, we generated humanized
ARMS2 knock-in mice. Human ARMS2 cDNA was inserted into the corresponding locus
upstream the Htra1 gene in mouse genome. Decline of Htra1 gene expression was
found in the cortex of ARMS2 KI mice using RT-qPCR technique. Our finding indicates
the presence of ARMS2 gene upstream Htra1 may manifest negative regulation effect
upon Htra1 expression. This new evidence revealed the complexity of how the two
genes might work together in the causal pathway of AMD. Furthermore, we provided a
novel and valuable animal model that could facilitate further research of AMD
pathogenesis.
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Introduction
Age-related macular degeneration (AMD) is a chronic disease which accounts for
8.7% of all blindness worldwide and the most prevalent cause of blindness in developed
countries especially among the elders [1][2][3]. AMD affects the central region of retina
(macula) which is responsible for visual acuity and color vision. As a chronic disease,
AMD can be classified into early, intermediate and advanced stage. Advanced AMD can
be further divided into two subtypes: geographic atrophy (late-stage dry AMD) and
neovascular AMD (wet AMD). Late-stage dry AMD results in loss of retinal pigment
epithelium (RPE) cell and overlying photoreceptors which leads to a progressive visual
impairment [4]. For wet AMD, new vessels sprout from choroid and break beneath the
retina, which causes permanent damage to adjacent retinal tissue and leads to central
vision loss [5].
The pathogenesis of AMD is poorly understood. It likely results from the
combination of multiple environmental and genetic factors. Notable environmental risk
factors include smoking, diet, alcohol use and infections [6]. Several AMD susceptibility
loci were also identified through genetic studies. Two chromosome regions, 1q31 and
10q26, were repeatedly associated with AMD in most studies and confirmed by a metaanalysis [7]. In 2005, several studies reported complement factor H (CFH) gene located
on chromosome 1q31 as the first AMD susceptibility gene and CFH Y402H was
recognized as a major AMD susceptibility variant [8][9]. On the other hand, several AMD
risk variants were found in a high linkage disequilibrium (LD) region on chromosome
10q26. This region encompasses three genes: pleckstrin homology domain-containing
A1 (PLEKHA1), age-related maculopathy susceptibility 2 (ARMS2, formerly named
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LOC387715), and HtrA serine peptidase 1 (HTRA1), which make it difficult to identify
which gene(s) is the causal one(s) [10]. Jakobosdottir et al. (2005) suggested PLEKHA1
is the major contributor to AMD susceptibility [11]. Rivera et al. (2005) found the
strongest association was centered over a coding SNP rs10490924 within ARMS2 [12].
Later, DeWan et al. (2006) and Yang et al. (2006) identified rs11200638 in the HTRA1
promoter as the most significantly associated variant of AMD and suggested that
increasing HTRA1 expression may play a role in AMD pathogenesis [5][13]. However,
Kanda et al. (2007) showed that rs10490924 in ARMS2 alone can explain the AMD
susceptibility, contradicted with former findings [14]. Since then, evidence have
emerged to demonstrate the strong association of rs10490924 and rs11200638 with the
risk of AMD in different studies, respectively. A meta-analysis summarized the results
and confirmed the association with AMD risk for both rs10490924 and rs11200638,
suggesting a moderate codominant, multiplicative genetic mode of ARMS2 and HTRA1
in the AMD pathogenesis [15]. Besides, another two important AMD susceptibility
variants have been identified: the indel polymorphism in the 3’ -UTR of ARMS2 and the
nonsense polymorphism rs2736911 (C>T: R38X) in the first exon of ARMS2 [16].
Because of the high LD across the ARMS2-HTRA1 locus, statistical genetics
method alone cannot determine which variant(s) is causative for AMD risk. Therefore,
molecular functional studies are required to investigate their roles in AMD pathogenesis.
Here we review the existing knowledge of ARMS2 and HTRA1 about their molecular
function with regard to AMD.
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ARMS2
ARMS2 is a primate-specific gene encoding a 11-kDa protein ARMS2 [17]. It
expresses strongly in the placenta but weakly in retinal tissues [18]. The structure,
cellular localization and function of the protein are unclear because of contradictory
results. A recent study suggested it may function in complement activation process;
deficiency of this protein may reduce the clearance of cellular debris and enhance
formation of drusen, the hallmark of AMD [19].
The effect of rs10490924 on the structure and function of ARMS2 is unclear.
Early evidence indicated that it may cause a nonsynonymous change A69S in ARMS2
protein [14]. The indel polymorphism in the 3’ -UTR of ARMS2 has been reported to
destabilize ARMS2 transcript and strongly associated with AMD [20]. The nonsense
polymorphism rs2736911 (C>T: R38X) in the first exon of ARMS2 was believed to
introduce a premature stop codon and eventually lead to less ARMS2 protein. However,
this variant is not positively associated with AMD, in contrast to the indel variant [18].
HTRA1
HTRA1 gene encodes a 51-kDa secreted serine protease (HTRA1) which is
widely expressed in many types of tissue including retina. HTRA1 protein can degrade
extracellular matrix (ECM) proteins as well as regulate signaling of transforming growth
factor-beta (TGFβ) family protein, insulin-like growth factor (IGF) and fibroblast growth
factors (FGF), playing important role in cell proliferation and migration [10][21][22].
Human HTRA1 gene has been linked with the microvascular and macrovasculature
diseases including arthritis, preeclampsia and tumor progression besides AMD [23].
3

There is a hypothesis about how HTRA1 may involve in the pathogenesis of AMD:
overexpressed HTRA1 protein would cause excess digestion of ECM, leading to
elevated levels of pro-inflammatory peptide fragments that increase oxidative stress and
eventually contributing to AMD [16].
The AMD-associated variant rs11200638 in HTRA1 promoter has been initially
suggested to increase HTRA1 expression [5][13]. Several follow up studies, on the
contrary, showed that rs11200638 may not increase HTRA1 expression level [14][24].
Overall, the results of how rs11200638 might affect HTRA1 expression remains
inconsistent. Besides, the adjacent indel polymorphism in the 3’ -UTR of ARMS2 was
suggested to have joint effect with rs11200638 to regulate HTRA1 expression
[16][25][26].
The genetic studies and functional studies till now have not yet reached a
consensus about the casual gene associated with AMD. Inspired by previous studies,
especially for those implied ARMS2 (and its downstream sequence) might regulate
HTRA1 expression, we think exploring the functional relationship between ARMS2 and
HTRA1 in vivo might shed light on solving the “causative” puzzle.
However, ARMS2 is a gene only present in Old World monkeys and apes
besides human [27], which make it difficult to investigate its function in commonly used
animal model such as mice. Several groups have created ARMS2 transgenic mice
[28][29]. In those mice, human ARMS2 gene was randomly inserted into their genome,
which makes the interaction between ARMS2 and Htra1 cannot be well examined.
Besides, these mice appeared normal and didn’t develop any typical AMD-related
cellular or molecular phenotype, indicating that proper genomic location of ARMS2
4

upstream Htra1 promoter might be crucial for the hypothetical regulation effect.
Therefore, we generated humanized ARMS2 knock-in mice by inserting human ARMS2
cDNA into the corresponding locus upstream the Htra1 gene in mouse genome. By
examining Htra1 expression in humanized ARMS2 knock-in mice, we could understand
the regulation relationship between these two genes.

Materials and Methods
General study design
Our goal is to detect possible Htra1 expression change in humanized ARMS2
knock-in mice. In order to make meaningful comparisons, two genotypes of mice with
humanized ARMS2 sequence were constructed. Genotyping was performed to identify
all mice’s genetic makeup. RNA was extracted from cortex or hippocampus from subject
mice. Cortex and hippocampus were chosen because previous results in our lab (in situ
hybridization) showed that Htra1 expression only presents in these two regions in
mouse brain. RT-qPCR, a widely-used method of quantitating gene expression, was
conducted to measure Htra1 expression in transcriptional level among different groups.
Data from RT-qPCR was collected and analyzed to compare the gene expression level.
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Animals
Three genotypes of mice were generated with the help of Ozgene (Perth,
Australia) for further experiment:
ARMS2 flox mice (ARMS2flox/flox)
ARMS2 knock-in (KI) mice (ARMS2KI/KI)
Wild type (WT) mice
Similar process was described in our previous study [30]. A targeting vector
using mouse Htra1 upstream homologous sequence was created (Figure 1). A Human
ubiquitin C (UbiC) promoter, a transcriptional stop sequence flanked by loxP sites, a
human ARMS2 cDNA tagged with a flag epitope, and a flippase recognition target
(FRT)-flanked phosphoglycerate kinase-1 (PGK)-neomycin cassette, were inserted
upstream of Htra1 promoter. The vector was then electroporated into embryonic stem
(ES) cells from C57BL/6 mice to generate chimeric mice. Further breeding was done to
create the three final genotypes. ARMS2 flox allele was created by removing selection
cassette through breeding with OzFlpE mice (FlpE knock-in mice). ARMS2 KI allele was
further generated by removing the loxP-flanked stop sequence through crossing to
germline-transmitting Rosa26-Cre mice. The WT mice and ARMS2 flox mice are
littermate. All mice were kept in C57BL/6 genetic background. All animal experiments
were conducted with the help of Dr. Jianyu Wu in accordance with Statement by Yale
University on the Humane Use of Animals in Research and Education.
As a result, ARMS2 should not be expressed in ARMS2 flox mice because of the
transcriptional stop sequence, while ARMS2 can be ubiquitous constitutively expressed
6

in ARMS2 KI mice. The rationale of this construction is to distinguish whether the
possible Htra1 expression level change derives from active ARMS2 gene expression
(transcriptional or post-transcriptional level) or genome structural change upstream
Htra1.
Targeting vector

FlpE ↓

ARMS2 flox allele

Cre ↓
ARMS2 KI allele

Figure 1 Construction of humanized ARMS2 knock in mice
A Ubic promoter, a stop sequence flanked by loxP sites, a human ARMS2 cDNA tagged with a flag
epitope and a FRT flanked neo cassette was inserted 5’ to Htra1 promoter. Expression of FlpE removes
the neomycin selection cassette. Expression of Cre causes excision of the stop sequence.
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Genotyping
Polymerase Chain Reaction (PCR) was performed to genotype each mouse:
REDExtract-N-Amp Tissue PCR Kit (Sigma) was used to extract DNA from mouse toe
tissue and perform further PCR process. Specific primer combinations were designed to
distinguish different alleles (Table 1). The expected bands for WT, ARMS2 flox and
ARMS2 KI alleles are 200 bp, 340 bp and 470 bp, respectively. Conventional PCR
program was used to amplify DNA (Table 2). Agarose gel (2%) electrophoresis was
performed to distinguish amplified DNA bands.
Table 1 PCR primers for genotyping

Alleles
ARMS2 flox allele

ARMS2 KI allele

Primers
5’-CTTTGGCAGCTATGGTGTCTCACCA-3’
5’-ACTTCTCATCCATCAGGTCTTGGCA-3’
5’-CCTGTTCCGCTCTCTGGAAAGAAAA-3’
5’-CTTTGGCAGCTATGGTGTCTCACCA-3’
5’-ACTTCTCATCCATCAGGTCTTGGCA-3’
5’-TATCATCCACACTGCAGCAAGGTGA-3’

Table 2 PCR program for genotyping (conventional PCR)

Temperature
94 ˚C
94 ˚C
60 ˚C
70 ˚C
70 ˚C
16 ˚C

Time
5 minutes
30 seconds
30 seconds
60 seconds
5 minutes
forever

Cycles
35 cycles
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RNA extraction
All mice were sacrificed around 18 to 20 days after birth. Cortex and
hippocampus tissues were dissected out from each mouse after perfusing them with
Phosphate Buffered Saline (PBS). Tissues were then quickly frozen on dry ice and
stored at -80°C, for preventing RNA degradation caused by RNase.
RNA was then extracted from those tissues. First, cortex or hippocampus tissues
were separately homogenized with motor pestles and dissolved in TRIzol
(ThermoFisher Scientific). Then, RNA was extracted by phenol-chloroform extraction
and precipitated by isopropyl alcohol. The RNA pellet was resuspended in RNase-free
water. RNA concentration was measured by Nanodrop spectrophotometer (Fisher
Scientific).
RT-qPCR
Real-time quantitative polymerase chain reaction (RT-qPCR) is a definitive
technique for quantitating differences in gene expression levels between samples [31].
The basic principle is as follow: first, fluorescent double-stranded (ds) DNA-binding dye
SYBR® Green was added into PCR system. Then the reaction was run in a RT-qPCR
instrument, in which the intensity of fluorescence after each cycle was measured.
Because SYBR® Green only emits fluorescence after binding with dsDNA, amplification
of templates can be quantitating through measuring the fluorescence. Usually, a
threshold for detection of fluorescence will be set up. The cycle number at which the
fluorescence reaches the threshold is called the Threshold Cycle (Ct). To measure gene
expression, the Ct of a housekeeping gene (for example, β-actin) from the same sample
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will be measure as well, in order to normalizing the variation of RNA amount among
different samples. The relative expression level can be calculated as follow:
𝑅𝑅 =

Iinterested gene

Ihousekeeping gene

=

Ct
T/2 interested gene

Ct
T/2 housekeeping gene

= 2𝐶𝐶𝑡𝑡housekeeping gene−𝐶𝐶𝑡𝑡interested gene = 2∆𝐶𝐶𝐶𝐶

(R=relative expression level; I=initial copy number; T=threshold; Ct=threshold cycle;)
In our study, RT-qPCR was used for quantitating the relative expression level of
both ARMS2 and Htra1 gene. First, same amount of RNA extracted from tissues was
used as template to reverse-transcribe to cDNA using iScriptTM Reverse Transcription
Supermix (Bio Rad). β-actin was used as housekeeping gene to normalize the RNA
expression level. Different primer combinations were designed for Htra1, β-actin or
ARMS2 gene (Table 3). RT-qPCR was performed using CFX96 Touch™ Real-Time
PCR Detection System (Bio-Rad). SYBR® Green JumpStart™ (Sigma) was used as
RT-qPCR fluorescent dye. RT-qPCR program is list in Table 4.
For each RNA sample, the reverse transcription process was duplicated. For
each cDNA sample, RT-qPCR was carried out three times in parallel. Ct was measured
for each run. The whole RT-qPCR experiment was thoroughly duplicated for valid result.
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Table 3 RT-qPCR primers for Htra1, β-actin and ARMS2

Genes
Htra1

β-actin
ARMS2

Primers
5’-TTGCTGATGTGGTGGAGAAG-3’
5’-CAATCAGTCCATCCTCCGATAC-3’
5’-GCCACCAGTTCGCCATGGA-3’
5’-TACAGCCCGGGGAGCATCGT-3’
5’-GTAAATTGTCCGCTAAATTCTGGCC-3’
5’-TTGTCGTCATCGTCCTTGTAGT-3’

Table 4 RT-qPCR program

Temperature
94 ˚C
94 ˚C
60 ˚C

Time
2 minutes
15 seconds
60 seconds

Cycles
40 cycles
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Data analysis
As the flow diagram (Figure 2) show, after RNA extraction, each RNA sample
generated two cDNA samples. Each cDNA sample underwent 3 parallel RT-qPCR,
generating 3 relative expression data (R1-R3). Mean 1 or Mean 2 is the average of
each triplicate RT-qPCR results. The whole experiment was duplicated, thus, two more
average expression data, Mean 3 and Mean 4, were generated. The final data for each
tissue sample from different mice we used to make comparisons, was the average of
the Mean 1 to Mean 4.
Cortex or hippocampus
RNA
cDNA 1
R1

R2
average

R3

cDNA 2
R1

Duplicate
R2
average

Mean 1

R3

Mean 2

Mean 3

Mean 4

average
Final data
Statistical analysis
Figure 2 Diagram of RT-qPCR data generating

Analysis of variance (ANOVA) was performed using the final average relative
expression level derived from ARMS2 flox mice, ARMS2 KI mice and wild type mice to
detect the difference of Htra1 expression. The Fisher Least Significant Difference (LSD)
method was used for multiple comparisons. All statistical analysis was done using IBM®
SPSS® Statistics 25 and GraphPad Prism 9.
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Results
Genotyping
The genotyping result is listed in Table 5. All of them were early adult mice aged
18 to 20 days after birth. 7 wild type mice, 7 ARMS2 flox mice and 9 ARMS2 KI mice
were used for further experiments.
Table 5 Mouse information and genotyping

Mouse number
369
370
490
494
496
498
503
372
373
487
489
491
497
502
249
251
253
254
255
726-1
726-2
726-3
726-4

Date of Birth
8/28/2019
8/28/2019
9/14/2019
9/14/2019
9/14/2019
9/12/2019
9/12/2019
8/28/2019
8/28/2019
9/14/2019
9/14/2019
9/14/2019
9/12/2019
9/12/2019
2/24/2020
2/24/2020
2/24/2020
2/24/2020
2/24/2020
7/7/2020
7/7/2020
7/7/2020
7/7/2020

Sacrifice date
9/18/2019
9/18/2019
10/2/2019
10/2/2019
10/2/2019
10/2/2019
10/2/2019
9/18/2019
9/18/2019
10/2/2019
10/2/2019
10/2/2019
10/2/2019
10/2/2019
3/13/2020
3/13/2020
3/13/2020
3/13/2020
3/13/2020
7/26/2020
7/26/2020
7/26/2020
7/26/2020
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Postnatal Date
20
20
18
18
18
20
20
20
20
18
18
18
20
20
18
18
18
18
18
19
19
19
19

genotype
WT
WT
WT
WT
WT
WT
WT
ARMS2 flox
ARMS2 flox
ARMS2 flox
ARMS2 flox
ARMS2 flox
ARMS2 flox
ARMS2 flox
ARMS2 KI
ARMS2 KI
ARMS2 KI
ARMS2 KI
ARMS2 KI
ARMS2 KI
ARMS2 KI
ARMS2 KI
ARMS2 KI

Detection of ARMS2 mRNA
ARMS2 mRNA was detected in cortex and hippocampus from ARMS2 KI mice,
while no signal was detected in cortex or hippocampus from ARMS2 flox mice or WT
mice (Table 6). The result showed ARMS2 expresses in cortex and hippocampus of
ARMS2 KI mice but not in other mice. It confirmed that our humanized ARMS2 KI
mouse model was well constructed. On the other hand, ARMS2 flox mice, despite
harboring ARMS2 cDNA, doesn’t actively express the gene.
Table 6 ARMS2 mRNA relative expression in cortex and hippocampus (final data)

Mouse number

Genotype

490
494
496
498
503
373
487
489
497
502
255
726-1
726-2
726-3
726-4

WT
WT
WT
WT
WT
ARMS2 flox
ARMS2 flox
ARMS2 flox
ARMS2 flox
ARMS2 flox
ARMS2 KI
ARMS2 KI
ARMS2 KI
ARMS2 KI
ARMS2 KI

ARMS2 Expression in
Cortex
Not detectable
Not detectable
Not detectable
Not detectable
Not detectable
Not detectable
Not detectable
Not detectable
Not detectable
Not detectable
.00048379
.00022148
.00031695
.00038163
.00030829
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ARMS2 Expression in
Hippocampus
Not detectable
Not detectable
Not detectable
Not detectable
Not detectable
Not detectable
Not detectable
Not detectable
Not detectable
Not detectable
.00025691
.00032346
.00051378
.00042213
.00046725

Quantification of Htra1 expression
Cortex
Htra1 relative expression level among different mice in cortex was shown in
Table 7 and Figure 3. Test of homogeneity of variance showed an insignificant result
(p=0.411), thus, one-way ANOVA is proper to use for comparison. ANOVA showed that
there was a significant difference (p=0.029) of Htra1 relative expression level among the
three groups of mice. Multiple comparisons revealed that the difference between
ARMS2 KI mice and WT mice (p=0.011), and the difference between ARMS2 flox mice
and WT mice (p=0.041) are both significant. Comparing to WT mice, Htra1 expression
in ARMS2 KI mice and ARMS2 flox mice decreased by 22% and 18% in average,
respectively. There was no significant difference between ARMS2 KI mice and ARMS2
flox mice regarding Htra1 relative expression level (p=0.641).
Hippocampus
Htra1 relative expression level among different mice in hippocampus was shown
in Table 7 and Figure 4. Test of homogeneity of variance showed an insignificant result
(p=0.529), thus, one-way ANOVA is proper to use. However, ANOVA detected no
significant difference of Htra1 relative expression level among the three groups of mice
(p=0.143).
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Table 7 Htra1 mRNA relative expression in cortex and hippocampus (final data)

Mouse number

Genotype

369
370
490
496
498
494
503
372
373
487
489
497
491
502
249
251
253
254
255
726-1
726-2
726-3
726-4

WT
WT
WT
WT
WT
WT
WT
ARMS2 flox
ARMS2 flox
ARMS2 flox
ARMS2 flox
ARMS2 flox
ARMS2 flox
ARMS2 flox
ARMS2 KI
ARMS2 KI
ARMS2 KI
ARMS2 KI
ARMS2 KI
ARMS2 KI
ARMS2 KI
ARMS2 KI
ARMS2 KI

Htra1 Expression in
Cortex
.10725
.12035
.11414
.11315
.11933
.07882
.13300
.11401
.08579
.08761
.12138
.07164
.06083
.10103
.10579
.08870
.07534
.08471
.11319
.07224
.09362
.07495
.07938
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Htra1 Expression in
Hippocampus
.11075
.11759
.10032
.13843
.12115
.06100
.13683
.09589
.09036
.08615
.11443
.07949
.05842
.07959
.10705
.11277
.08932
.15546
.07150
.08752
.12657
.08099
.09463

0.15

✱

ns

0.10

0.05

S2
M
A
R

A
R

M

S2

W

flo

K

I

x

0.00
T

Htra1 expression relative to β-actin

✱

Figure 3 Htra1 expression relative to β-actin in cortex
The boxs indicate upper and lower quartiles. The whiskers indicate the maximun and the minimum. * and
ns indicate significant difference and nonsignificant difference in multiple comparisons (LSD),
respectively. ANOVA: N=7 (WT), 7 (ARMS2 flox), 9 (ARMS2 KI).
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0.10

0.05

S2

A

R

A

R

M

M
S2

W

flo
x

K
I

0.00

T

Htra1 expression relative to β-actin

0.15

Figure 4 Htra1 expression relative to β-actin in hippocampus
ANOVA: N=7 (WT), 7 (ARMS2 flox), 9 (ARMS2 KI).
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Discussion
Although AMD is one leading cause of irreversible visual loss, the pathogenesis
of it remains enigmatic till now. Genetic studies located several AMD susceptibility loci
including two chromosome regions, 1q31 and 10q26. Evidence has emerged to support
the association of AMD with each of the three candidate genes (later evidence
pinpointed two genes, ARMS2 and HTRA1) within 10q26. However, due to the
existence of high LD across the region, statistical genetic analysis alone cannot
definitively distinguish the causal one that confer the risk of AMD. Therefore, molecular
functional studies became the better way to solve the puzzle. Little is known about the
structure and function of ARMS2 protein. Several AMD-associated variants in ARMS2
gene such as rs10490924, rs2736911 and the indel in 3’ -UTR of ARMS2 were
identified, though how they might contribute to AMD pathogenesis remains inconsistent.
More information is available for the function of HTRA1 protein: overexpressed HTRA1
has been hypothesized to digest excessive ECM and elevate oxidative stress to
facilitate AMD pathogenesis. However, there is no consensus about how associated
variants (such as rs11200638) might affect HTRA1 expression. In summary, current
evidence is inadequate to answer the causality question.
In order to provide insight of the functional roles of ARMS2 and HTRA1 in the
pathogenesis of AMD, we decided to explore the regulation relationship between the
two genes. To overcome the fact that ARMS2 gene only exists in higher primates, we
generated humanized ARMS2 knock-in mice to investigate Htra1 expression in vivo.
ARMS2 flox mice was also generated to distinguish whether the possible Htra1
expression change derives from active ARMS2 expression or genome structural change
19

upstream Htra1. Cortex and hippocampus were chosen for subsequent experiments.
RNA was extracted and reverse-transcribed to cDNA. RT-qPCR was then performed to
quantitate Htra1 expression in different genotypes of mice.
We found significant difference of Htra1 expression in cortex among three
genotypes of mice. Htra1 expression decreased by 22% and 18% for ARMS2 KI mice
and ARMS2 flox mice, compared to wild type mice. Multiple comparisons also
confirmed the significant decrease for both ARMS2 KI mice and ARMS2 flox mice but
cannot distinguish these two genotypes of mice regarding their Htra1 expression. This
finding indicates that the presence of ARMS2 gene upstream Htra1 promoter manifests
regulation effect upon Htra1 expression in mouse model, also implying this relationship
may exist in human. However, since we only observed ARMS2 mRNA in ARMS2 KI
mice but not in ARMS2 flox mice, we suspect this regulation relationship may not
depend on the expression of ARMS2 gene. Since ARMS2 is quite closed to Htra1
promoter region, ARMS2 gene sequence itself may cooperate with Htra1 promoter to
regulate Htra1 expression. Nevertheless, based on our data, we assume that ARMS2
gene may negatively regulate Htra1 gene expression. Thus, mutant variants which
change the original sequence of ARMS2 gene may distort the normal regulation
relationship and lead to abnormal expression of Htra1. This hypothesis is partially
consistent with previous evidence supporting that the indel variant in the 3’-UTR of
ARMS2 can enhance Htra1 expression24.
We didn’t find significant difference of Htra1 expression in hippocampus among
three genotypes of mice, implying the regulation effect may present in a tissue-specific
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manner, although individual variation among mice and relatively small sample size
could be alternative explanations.
Yet the pathogenesis of AMD regarding the controversy of ARMS2 and HTRA1
remain unclear, a “dual causality hypothesis” which supports that both increased
HTRA1 and decreased ARMS2 mediate AMD seem to be the answer suits for all
observations [16][23]. Our findings provide new evidence of the functional link between
ARMS2 and Htra1, revealing the complexity of how the two genes might work together
in the causal pathway of AMD. Future studies should consider the regulation effect
when dissect the contribution towards AMD of one of the two genes.
The prominent strength of this study is the novel design of the humanized
ARMS2 knock-in mouse model. This construction solves the problem that higherprimate-specific gene ARMS2 is intractable to investigate in model organisms, and will
facilitate further research in this area. There are several limitations as well. First, we
only chose early adult mice (18-20 day, postnatal) as our subjects. The fluctuation of
ARMS2 and Htra1 expression in mice’s developmental process was ignored. Thus, we
may miss the critical period when ARMS2 and Htra1 function in AMD pathogenesis.
Second, we chose cortex and hippocampus based on our previous evidence such as in
situ hybridization. The inconsistent result from cortex and hippocampus is hard to
interpret, which reflects the logistic difficulty. To query the association with AMD
pathogenesis, retinal tissue could be a better choice since retina is the major affected
site of AMD. However, ARMS2 is only faintly expressed in retina [18]. Our previous
work didn’t detect ARMS2 expression in retina either, which make the question hard to
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tackle. Finally, the sample size is relatively small, which may let the true difference be
covered up by the influence of individual variation of gene expression.
In the future, we could further design ARMS2 knock-in mice carrying AMD risk
variants such as rs10490924, rs2736911 and the indel in 3’ -UTR of ARMS2 to
investigate their respective influence towards Htra1 expression, and compare their
effect with the original ARMS2 allele. These comparisons could further validate the
regulation relationship between ARMS2 gene and Htra1 gene. Besides, more elaborate
detection of both ARMS2 protein and HTRA1 protein in eye tissue could be performed
to ultimately ascertain the level of ARMS2-Htra1 interplay.
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